Title: Cryoprecipitate in Patients with Coagulopathy Associated with Massive Blood Transfusion after the Application
Abstract: Objective Observed after massive blood transfusion in patients with coagulation abnormalities associated with the role of cryoprecipitate infusion.Method 14 cases of serious injury after massive blood transfusion in patients with abnormal blood clotting,transmission line before the cryoprecipitate,cryoprecipitate lost after 8-24 hours and 3-5 days after the input level of coagulation as measured,D-dimer.Results In patients with prothrombin time(PT),thrombin time(TT),partial thromboplastin time(APTT) were significantly reduced,fibrinogen(Fbg) content increased,14 patients with D-dimer to negative.Conclusion Complicated by the large number of blood clotting abnormalities in patients with timely infusion of cryoprecipitate,can improve blood circulation and coagulation factor fibrinogen and other clotting substances,reducing clotting time,to correct coagulation abnormalities.
Publication Year: 2012
Publication Date: 2012-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot